Health Policy Guidance and Advisory Statements
-
ISHLT Statement on Transplant Ethics27 June 2022
ISHLT holds that there should be explicit policies, open to public scrutiny, governing all aspects of organ/tissue donation and transplantation, including the management of waiting lists for organs to ensure fair and appropriate access to transplantation.
-
Guidance for Organ Donation and Transplantation Professionals Regarding the Zika Virus4 February 2016
After careful review of the information available from the CDC, OPTN/UNOS, AST, and ASTS provide the information in this document for transplant centers and OPOs in light of the spread of Zika virus.
-
Generic Drug Immunosuppression in Thoracic TransplantationAn ISHLT Educational Advisory4 June 2009
The purpose of this educational advisory from 2009 was to provide an international perspective on regulatory and clinical concerns with generic immunosuppression medications in thoracic transplantation.
-
ISHLT Advisory Statement on the Implications of Pandemic Influenza for Thoracic Organ Transplantation15 May 2009
This advisory statement regarding the implications the swine influenza A (H1N1) on transplantation has been produced by the ISHLT to complement existing official guidance from national and international public health agencies